Amedra Pharmaceuticals recalls
Amedra Pharmaceuticals has 4 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 1 Jan 2014. The most frequent reason is potency & assay.
Total recalls4since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 1 Jan 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why amedra pharmaceuticals is recalled
Product types
By year
All amedra pharmaceuticals recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Dexedrine¿ (Dextroamphetamine Sulfate) Spansules¿ recalled | Amedra Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Dextroamphetamine Sulfate Extended Release Capsules, 5 mg recalled | Amedra Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Dextroamphetamine Sulfate Extended Release Capsules, 5 mg recalled | Amedra Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Dextroamphetamine Sulfate Extended Release Capsules, 5 mg recalled | Amedra Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.